Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 28, 2017
Pharmacy Choice - Pharmacy News - June 28, 2017

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
6/28/17 - Data on Vaccines Reported by Researchers at Georgia Institute of Technology (Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric...
Data on Vaccines Reported by Researchers at Georgia Institute of Technology. According to news originating from Atlanta, Georgia, by NewsRx correspondents, research stated, "Despite decades of research very few vaccine-adjuvants have received FDA approval. Our news journalists obtained a quote from the research from the Georgia Institute of Technol
6/28/17 - EC Clears Sandoz`s Erelzi Biosimilar Etanercept Copy of Amgen`s Enbrel [Sudan Tribune]
Carol Lynch, global head, biopharmaceuticals at Sandoz, the Novartis biosimilars operation, said "Immunology is a priority for us, and today`s approval of Erelzi, the second in this therapy area in as many weeks, clearly demonstrates our commitment to patients. FDA approved Erelzi back in August 2016, but an ongoing patent lawsuit, instigated by Am
6/28/17 - FDA approves cryopreserved formulation of ReNeurons candidate [Syrian Arab News Agency]
The FDA has approved the cryopreserved formulation of ReNeurons human retinal progenitor cell therapeutic candidate and have started treating patients with this formulation in their ongoing US Phase I/II study clinical trial in retinitis pigmentosa patients. Olav Helleb, Chief Executive Officer of ReNeuron, said:. This is a further significant...
6/28/17 - Glenmark gets USFDA nod for generic anti-inflammatory drug [Arab Finance (Egypt)]
Glenmark Pharmaceuticals has received final approval from the US health regulator for its generic version of anti-inflammatory drug Indomethacin tablets. The approval granted to Glenmark Pharmaceuticals Inc by the US Food and Drug Administration is for Indomethacin extended-release capsules of 75 mg strength, the company said in a statement today.
6/27/17 - Benznidazole IND for Chagas Disease Receives Clearance by FDA
--KaloBios Pharmaceuticals, Inc., a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today announced its Investigational New Drug application for benznidazole is open, and a key part of the program can proceed as planned toward gaining potential approval as a treatment for Chagas disease, a neg
6/27/17 - Collins said drug company had no business before feds -- but it does [The Buffalo News, N.Y.]
"Innate Immunotherapeutics Limited is pleased to confirm it has received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug application lodged last month," the company said in the first paragraph of a news release issued on Wednesday. All of this could provide more information for the Office of Congressi

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415